Nora Bayani

4.6k total citations
9 papers, 312 citations indexed

About

Nora Bayani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nora Bayani has authored 9 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Nora Bayani's work include Bioinformatics and Genomic Networks (3 papers), Computational Drug Discovery Methods (2 papers) and Gene Regulatory Network Analysis (2 papers). Nora Bayani is often cited by papers focused on Bioinformatics and Genomic Networks (3 papers), Computational Drug Discovery Methods (2 papers) and Gene Regulatory Network Analysis (2 papers). Nora Bayani collaborates with scholars based in United States, United Kingdom and Netherlands. Nora Bayani's co-authors include Joe W. Gray, James E. Korkola, Zhi Hu, Marc E. Lenburg, Eleanor A. Blakely, Ge Huang, Anguraj Sadanandam, Shenda Gu, Jian‐Hua Mao and Sach Mukherjee and has published in prestigious journals such as Nature Communications, Bioinformatics and Cancer Research.

In The Last Decade

Nora Bayani

9 papers receiving 310 citations

Peers

Nora Bayani

MB

PRM

ONCOL

CR

CB

Eleftherios Pilalis Greece

Khyati N. Shah United States

Leandra Sepe Italy

Zhigang Charles Wang United States

Manasi K. Mayekar United States

Dale A. Begley United States

A Kahn United States

Emanuela Gadaleta United Kingdom

Elizabeth Mouchet United Kingdom

Berta Martín Spain

Eleftherios Pilalis Greece

Nora Bayani

257 ×1.0

MB

43 ×0.6

PRM

46 ×0.8

ONCOL

64 ×1.2

CR

46 ×1.2

CB

Citations per year, relative to Nora Bayani Nora Bayani (= 1×) peers Eleftherios Pilalis

Countries citing papers authored by Nora Bayani

Since Specialization

Citations

This map shows the geographic impact of Nora Bayani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Bayani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Bayani more than expected).

Fields of papers citing papers by Nora Bayani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Bayani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Bayani. The network helps show where Nora Bayani may publish in the future.

Co-authorship network of co-authors of Nora Bayani

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Bayani. A scholar is included among the top collaborators of Nora Bayani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Bayani. Nora Bayani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kandyba, Eve, Kyle Halliwill, Reyno Delrosario, et al.. (2025). Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage. Cancer Discovery. 15(6). 1115–1128. 2 indexed citations

2.

Chen, Wei-Ching, Minh D. To, Peter M.K. Westcott, et al.. (2021). Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nature Communications. 12(1). 4288–4288. 34 indexed citations

3.

Smith, Rebecca, Moqing Liu, Tiera Liby, et al.. (2020). Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Scientific Reports. 10(1). 21750–21750. 38 indexed citations

4.

Donnella, Hayley, James T. Webber, Rebecca S. Levin, et al.. (2018). Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nature Chemical Biology. 14(8). 768–777. 67 indexed citations

5.

Oates, Chris J., Frank Dondelinger, Nora Bayani, et al.. (2014). Causal network inference using biochemical kinetics. Bioinformatics. 30(17). i468–i474. 35 indexed citations

6.

Hill, Steven M., Richard M. Neve, Nora Bayani, et al.. (2012). Integrating biological knowledge into variable selection: an empirical Bayes approach with an application in cancer biology. BMC Bioinformatics. 13(1). 22 indexed citations

7.

Hu, Zhi, Ge Huang, Anguraj Sadanandam, et al.. (2010). The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. Breast Cancer Research. 12(2). R18–R18. 109 indexed citations

8.

Semeiks, Jeremy R., Frederick L. Baehner, Nora Bayani, et al.. (2010). ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells. 3(1). 89–100. 4 indexed citations

9.

Hu, Zhanying, Jian‐Hua Mao, Guanhao Huang, et al.. (2009). A Systems Analysis of Mitotic Apparatus Inhibitors Defines a Response Network for Breast Cancer.. Cancer Research. 69(24_Supplement). 2020–2020. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact